Effects of serotonin-norepinephrine reuptake inhibitors on locomotion and prefrontal monoamine release in spontaneously hypertensive rats.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Pharmacology

• Publication date

  2013-02-28

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.ejphar.2013.01.033PMID 23376565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duloxetine in Adults With ADHD

  2014cited by this paper
• The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.

  2012cited by this paper
• The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats.

  2012cited by this paper
• Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders.

  2011cited by this paper
• Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ1 receptor activation

  2011cited by this paper
• Animal models of attention-deficit/hyperactivity disorder.

  2011cited by this paper
• Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open‐label study

  2011cited by this paper
• Regulation of Extracellular Dopamine: Release and Uptake

  2010cited by this paper
• Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.

  2010cited by this paper
• Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

  2010influential reference
• Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial

  2010cited by this paper
• Adolescent and Adult Male Spontaneous Hyperactive Rats (SHR) Respond Differently to Acute and Chronic Methylphenidate (Ritalin)

  2009cited by this paper
• The Emerging Neurobiology of Attention Deficit Hyperactivity Disorder: The Key Role of the Prefrontal Association Cortex.

  2009cited by this paper
• Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder

  2008cited by this paper
• Venlafaxine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2007cited by this paper
• Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.

  2007cited by this paper
• Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.

  2007cited by this paper
• Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain.

  2007cited by this paper
• The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

  2007cited by this paper
• The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.

  2006cited by this paper
• Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function.

  2006cited by this paper
• Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.

  2006cited by this paper
• Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex.

  2006cited by this paper
• Early androgen treatment influences the pattern and amount of locomotion activity differently and sexually differentially in an animal model of ADHD.

  2006cited by this paper
• Subchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of rats.

  2005cited by this paper
• What Is the Prevalence of Adult ADHD? Results of a Population Screen of 966 Adults

  2005cited by this paper
• Rodent models of attention-deficit/hyperactivity disorder.

  2005cited by this paper
• DIFFERENTIAL LOCOMOTOR RESPONSES IN MALE RATS FROM THREE STRAINS TO ACUTE METHYLPHENIDATE

  2004cited by this paper
• Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder.

  2004cited by this paper
• Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness

  2003cited by this paper
• Strain differences in the behavioral responses of male rats to chronically administered methylphenidate.

  2003cited by this paper
• Animal models of attention-deficit hyperactivity disorder.

  2003cited by this paper
• Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.

  2003cited by this paper
• Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.

  2002cited by this paper
• A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

  2002influential reference
• Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder

  2002cited by this paper
• S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

  2001influential reference
• Pharmacological Alternatives to Psychostimulants for the Treatment of Attention-Deficit/Hyperactivity Disorder

  2000cited by this paper
• Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder.

  2000cited by this paper
• Epidemiology of ADHD in school-age children.

  2000cited by this paper
• Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity.

  1999cited by this paper
• Regulation of Extracellular Dopamine by the Norepinephrine Transporter

  1998cited by this paper
• Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter

  1998cited by this paper
• Contribution of Blockade of the Noradrenaline Carrier to the Increase of Extracellular Dopamine in the Rat Prefrontal Cortex by Amphetamine and Cocaine

  1997cited by this paper
• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  1997cited by this paper
• Comparative evaluation of [3H]WIN 35428 and [3H]GBR 12935 as markers of dopamine innervation density in brain

  1997cited by this paper
• Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.

  1996cited by this paper
• Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex.

  1995cited by this paper
• Novel halogenated analogs of tomoxetine that are potent and selective inhibitors of norepinephrine uptake in brain.

  1995cited by this paper
• Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites.

  1993cited by this paper
• Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome.

  1993cited by this paper
• Treatment of ADHD with fluoxetine: a preliminary trial.

  1991cited by this paper
• Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals

  1990cited by this paper

• Phasic dopamine release in two different rat models of attention-deficit/hyperactivity disorder: Spontaneously hypertensive rats (SHR) versus Lphn3 knockout rats.

  2025cites this paper
• Revisiting the Role of Serotonin in Attention-Deficit Hyperactivity Disorder: New Insights from Preclinical and Clinical Studies

  2025cites this paper
• Role of serotonin in the neurobiology of attention-deficit/hyperactivity disorder: a systematic literature review

  2025cites this paper
• Discriminating evidence – use and misuse of the drug-discrimination test in abuse potential assessment of novel CNS drugs

  2025cites this paper
• Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M Subjects

  2025cites this paper
• Traditional Chinese Medicine Research on Attention Deficit Hyperactivity Disorder:Theory, treatment and mechanism

  2024cites this paper
• Rat model of attention-deficit hyperactivity disorder exhibits delayed recovery from acute incisional pain due to impaired descending noradrenergic inhibition

  2023cites this paper
• Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease

  2023cites this paper
• Modulating Ketamine’s Locomotor Activating and Reinforcing Effects Through Drug Combinations

  2022cites this paper
• Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology

  2021cites this paper
• Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence.

  2021cites this paper
• SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.

  2020cites this paper
• Systematic review and meta-analysis of the behavioral effects of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder

  2019cites this paper
• On the Effects of Sensory Noise in ADHD

  2018cites this paper
• Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models

  2018cites this paper
• Effects of taurine on resting-state fMRI activity in spontaneously hypertensive rats

  2017cites this paper
• Effektivität und klinische Anwendung von Milnacipran

  2017cites this paper
• Effects of venlafaxine and chronic unpredictable stress on behavior and hippocampal neurogenesis of rat dams.

  2017cites this paper
• Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

  2017cites this paper
• Milnacipran in der Praxis

  2016cites this paper
• Long-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors

  2016cites this paper
• Psychopharmacological Studies in Mice.

  2016cites this paper
• Clock genes, ADHD and aggression

  2016cites this paper
• Category: Regular research articles

  2016cites this paper
• Adolescent methylphenidate treatment differentially alters adult impulsivity and hyperactivity in the Spontaneously Hypertensive Rat model of ADHD.

  2016cites this paper
• Sensitivity of [11C]ORM-13070 to increased extracellular noradrenaline in the CNS – a PET study in human subjects

  2015cites this paper
• Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice

  2015cites this paper
• Tph2 gene deletion enhances amphetamine‐induced hypermotility: effect of 5‐HT restoration and role of striatal noradrenaline release

  2015cites this paper
• Does serotonin deficit mediate susceptibility to ADHD?

  2015cites this paper
• Inhibition of hyperactivity and impulsivity by carbonic anhydrase inhibitors in spontaneously hypertensive rats, an animal model of ADHD

  2015cites this paper
• Acoustic noise improves motor learning in spontaneously hypertensive rats, a rat model of attention deficit hyperactivity disorder.

  2015cites this paper
• Noradrenergic modulation of risk/reward decision making

  2015cites this paper
• D-amphetamine improves attention performance in adolescent Wistar, but not in SHR rats, in a two-choice visual discrimination task

  2015cites this paper
• The alpha2C-adrenoceptor as a neuropsychiatric drug tar-get - PET studies in human subjects

  2015cites this paper
• Dorsal Raphe Neuroinflammation Promotes Dramatic Behavioral Stress Dysregulation

  2014cites this paper
• Atomoxetine-Induced Increases in Monoamine Release in the Prefrontal Cortex are Similar in Spontaneously Hypertensive Rats and Wistar-Kyoto Rats

  2014cites this paper
• Transcriptional Evidence for the Role of Chronic Venlafaxine Treatment in Neurotrophic Signaling and Neuroplasticity Including also Glutatmatergic- and Insulin-Mediated Neuronal Processes

  2014cites this paper
• The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.

  2014cites this paper
• Effects of acute and chronic administration of venlafaxine and desipramine on extracellular monoamine levels in the mouse prefrontal cortex and striatum.

  2014cites this paper
• Noradrenergic Terminals Regulate l‐DOPA‐derived Dopamine Extracellular Levels in a Region‐dependent Manner in Parkinsonian Rats

  2014cites this paper
• Neuroinflammatory regulation of stress behavior and physiology

  2014cites this paper
• Characterisation of Foxp1 in striatal development and the adult brain

  2013influential citation
• Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention–deficit/hyperactivity disorder, through &agr;2-adrenoceptor activation

  2013cites this paper
• METHYLPHENIDATE AND ATOMOXETINE TREATMENT DURING ADOLESCENCE IN THE SPONTANEOUSLY HYPERTENSIVE RAT: MECHANISMS UNDERLYING HIGH COCAINE ABUSE LIABILITY IN ATTENTION DEFICIT/HYPERACTIVITY DISORDER

  2013cites this paper